Simultaneous endoscopic management of prostatic and seminal vesicle abscess using holmium laser enucleation of the prostate and seminal vesiculoscopy: a case series Authors: Guiyang Zhang, Jingqun Wang, Wei Lu, Ruizhe Zhao Published: 2026 ABSTRACT BackgroundProstatic abscess (PA) is uncommon but potentially life-threatening. Secondary seminal vesicle abscess (SVA) is extremely rare and lacks standardized minimally invasive treatment. We report a case series evaluating holmium laser enucleation of the prostate (HoLEP) and seminal vesiculoscopy for the simultaneous drainage of these abscesses via a single endoscopic access.Case presentationTwo Han-Chinese men (aged 82 and 56 years) presented with LUTS, fever and imaging-confirmed PA; the younger also had a multi-loculated right SVA. The prostate volumes were approximately 75 mL (Case 1) and 50 mL (Case 2). The prostatic abscesses measured 33 × 34 mm (Case 1) and 27 × 15 mm (Case 2), with the right seminal vesicle abscess measuring 40 × 24 mm (Case 2). After culture-directed antibiotics and glycemic control, both patients underwent single-session endoscopic surgery: Case 1 HoLEP alone; Case 2 seminal vesiculoscopy followed immediately by HoLEP. Operative times were 50 minutes and 60 minutes; blood loss < 50 mL. No intraoperative or major postoperative complications were encountered (transient stress urinary incontinence in Case 1 resolved spontaneously within 1 week). Catheters were removed on postoperative days 5 and 4; Qmax improved to 20 mL/second and 22 mL/second and IPSS fell from 25 to 9 and 26 to 8 at 1 month. Imageological examination at 1 month showed complete resolution of abscess cavities with no recurrence.ConclusionsHoLEP appears to be a viable option for PA drainage and simultaneous relief of bladder-outlet obstruction. Combined HoLEP plus seminal vesiculoscopy may offer a feasible, single-access minimally invasive strategy for complex prostatovesicular abscesses, though long-term follow-up is necessary to definitively confirm efficacy and recurrence rates. Introduction Prostatic abscess (PA) is a rare but serious condition, accounting for approximately 0.5% to 2.5% of all prostatic diseases. Despite the widespread use of broad-spectrum antibiotics, the reported mortality rate remains between 1 and 16% [1]. PA is particularly prevalent in high-risk populations, including immunocompromised individuals, patients with diabetes mellitus, and those with lower urinary tract obstruction (LUTS) [2]. The cornerstone of PA management is systemic antibiotics combined with surgical drainage. While small abscesses (< 1 cm) may resolve with antibiotic monotherapy, larger or multi-loculated lesions require surgical intervention [3]. Traditional drainage methods include image-guided needle aspiration and transurethral unroofing (TURP-U) [4]. Recently, Holmium Laser Enucleation of the Prostate (HoLEP), a standard technique for benign prostatic hyperplasia (BPH), has been utilized for PA. HoLEP offers the advantage of complete abscess debridement while simultaneously managing underlying BPH. Secondary seminal vesicle abscess (SVA) following PA is an extremely rare complication that causes severe genitourinary infection. Due to its low incidence, standardized consensus regarding optimal management is lacking [5]. Similarly, seminal vesiculoscopy is primarily used for intractable hematospermia and ejaculatory duct obstruction, with very limited reports on its use for SVA drainage. Given the clinical challenge posed by combined prostatovesicular abscesses, we present our preliminary experience. This report details two distinct cases: a PA treated successfully with HoLEP, and a complex PA complicated by secondary SVA managed with combined HoLEP and seminal vesiculoscopy. This series explores the feasibility and effectiveness this combined endoscopic strategy for treating rare prostatovesicular abscesses. Case presentation Case 1 A previously healthy 82-year-old Han Chinese male presented with a 3-year history of progressive dysuria culminating in acute urinary retention one day prior to admission. An indwelling catheter had been placed at a local health clinic. The patient’s medical history was significant for hypertension and Type 2 diabetes mellitus (poorly controlled). Upon physical examination, his International Prostate Symptom Score (IPSS) was 25, and the Quality of Life (QOL) score was 5. Digital rectal examination (DRE) revealed Grade III prostatic enlargement with a firm consistency and a shallow central sulcus; no tenderness, nodules, or obvious fluctuation were detected. Upon admission, laboratory tests indicated systemic inflammation: the white blood cell (WBC) count was 11.3 × 109/L (with 96.8% neutrophils), and C-reactive protein (CRP) was significantly elevated at 38.92 mg/L. However, procalcitonin (PCT) was low 0.08 ng/mL, and interleukin-6 (IL-6) was elevated 88.2 pg/mL. Prostate-specific antigen (PSA) was 5.4 ng/mL Urinalysis showed mild pyuria (WBC: 10/uL) but was negative for nitrite. Importantly, both blood and urine cultures were negative. Hyperglycemia was confirmed by a postprandial blood glucose of 13.18 mmol/L and HbA1c of 6.4%. Imaging studies: urinary system ultrasonography initially suggested prostatic hyperplasia with an intraparenchymal hypoechoic area, raising suspicion of an abscess. Subsequent prostate magnetic resonance imaging (MRI) confirmed significant prostatic hyperplasia with an estimated prostate volume of approximately 75 mL and clearly delineated a large abscess cavity located within the left lobe, measuring approximately 33 × 34 mm (Fig. 1). The lesions were assessed as PIRADS 2 (clinically significant prostate cancer highly unlikely), consistent with inflammatory changes. Chest Computed Tomography (CT) ruled out active lung lesions.Fig. 1Preoperative prostate magnetic resonance imaging (MRI) indicated a huge abscess in the left lobe of the prostate. A Sagittal view. B Coronal view. C Axial view. D Axial diffusion-weighted imaging (DWI) Preoperative prostate magnetic resonance imaging (MRI) indicated a huge abscess in the left lobe of the prostate. A Sagittal view. B Coronal view. C Axial view. D Axial diffusion-weighted imaging (DWI) Treatment and outcome: empiric anti-infective therapy with cefoperazone sodium and sulbactam sodium (3.0 g every 12 hours, intravenously) was initiated immediately upon admission. Blood and urine cultures were negative, and prostatic pus culture obtained intraoperatively also showed no bacterial growth, likely due to prior antibiotic exposure. The patient received a total of 14 days of antibiotic therapy (7 days intravenous followed by 7 days oral cefixime). On the fourth day of hospitalization, HoLEP was performed under general anesthesia using the en bloc enucleation technique. Intraoperatively, abscess rupture occurred during the dissection of the plane between the left lateral lobe and the surgical capsule, leading to the overflow of a large volume of purulent material (Fig. 2). The abscess drainage and prostatic enucleation were completed successfully with a total operative time of 50 minutes. Tissue morcellation was performed using the VersaCut Tissue Morcellator (Lumenis Ltd.), with a morcellation time of approximately 8 minutes.Fig. 2During the holmium laser enucleation of the prostate (HoLEP) procedure, the prostate abscess ruptured and the pus flowed out During the holmium laser enucleation of the prostate (HoLEP) procedure, the prostate abscess ruptured and the pus flowed out The catheter was removed on postoperative day 5. The patient achieved successful voiding and was subsequently discharged. Temporary postoperative stress urinary incontinence was observed, but it completely resolved within one week. At the 1-month follow-up, the patient reported significantly improved lower urinary tract symptoms: maximum urinary flow rate (Qmax was 20 mL/second, IPSS 9, and QOL improved to 2. Genitourinary ultrasound demonstrated typical postoperative prostatic changes with no recurrence was observed within the short-term follow-up period (Fig. 3). The morcellated prostatic tissue was sent for histopathological examination, which confirmed benign prostatic hyperplasia with marked acute and chronic inflammation. No evidence of malignancy was found.Fig. 3Genitourinary ultrasound showed postoperative changes of the prostate, with no recurrence of abscess was observed within the short-term follow-up period Genitourinary ultrasound showed postoperative changes of the prostate, with no recurrence of abscess was observed within the short-term follow-up period Case 2 A 56-year-old Han Chinese male was admitted presenting with a 2-week history of dysuria and a 1-week history of right scrotal pain and swelling accompanied by chills and profound fatigue. The patient had a significant medical history including hypertension, cerebral infarction, coronary stent implantation, and poorly controlled Type 2 diabetes mellitus. Initial physical examination revealed severe lower urinary tract symptoms (IPSS: 26, QOL: 5) and a diminished flow rate (Qmax: 7 mL/second). DRE indicated Grade II prostatic enlargement with marked tenderness and fullness over the right lobe, but no obvious fluctuation or rectal bleeding. Laboratory tests confirmed severe systemic and local infection: the WBC count was 10.27 × 109/L (with 75.30% neutrophils), CRP was highly elevated at 69.93 mg/L, and PCT was elevated at 0.48 ng/mL. Urinalysis demonstrated severe pyuria (WBC: 1344/uL) and glucosuria (4 +) but was nitrite negative. Urine culture was negative. PSA was 6.7 ng/mL. Crucially, the patient's diabetes was extremely poor controlled, evidenced by a postprandial blood glucose of 21.67 mmol/L and a critically high HbA1c of 14.80%. Chest Computed Tomography (CT) ruled out remote active lesions. Imaging confirmation: initial urinary and scrotal ultrasound suggested hypoechoic areas in the right prostate lobe and the right seminal vesicle, along with concurrent right epididymitis. Prostate MRI provided definitive diagnosis, revealing prostatic hyperplasia with an estimated prostate volume of approximately 65 mL, a multi-loculated abscess in the right lobe (largest focus approximately 27 × 15 mm), and a right seminal vesicle abscess (SVA) measuring approximately 40 × 24 mm (Fig. 4). The prostatic lesions were assessed as PIRADS 2, consistent with benign inflammatory pathology rather than malignancy. This was further corroborated by transrectal ultrasound (TRUS) (Fig. 5).Fig. 4Prostate magnetic resonance imaging (MRI) showed prostatic hyperplasia, a multi-loculated abscess in the right lobe and a right seminal vesicle abscess. A Sagittal view. B Axial view. C Coronal view. D Axial diffusion-weighted imaging (DWI)Fig. 5Transrectal ultrasound showed prostatic abscess and seminal vesicle abscess. A Multiloculated abscess of the right lobe of the prostate. B Right seminal vesicle abscess Prostate magnetic resonance imaging (MRI) showed prostatic hyperplasia, a multi-loculated abscess in the right lobe and a right seminal vesicle abscess. A Sagittal view. B Axial view. C Coronal view. D Axial diffusion-weighted imaging (DWI) Transrectal ultrasound showed prostatic abscess and seminal vesicle abscess. A Multiloculated abscess of the right lobe of the prostate. B Right seminal vesicle abscess Treatment and outcome: upon admission, the patient received intensive medical management, including diabetic diet control, insulin therapy for strict glycemic control, and empiric anti-infective therapy with piperacillin sodium and sulbactam sodium. After 6 days of preparatory anti-infective treatment, a complex procedure involving seminal vesiculoscopy combined with HoLEP was performed under general anesthesia. Seminal vesiculoscopy was performed first; upon entry into the right seminal vesicle, viscous purulent material was immediately visualized and meticulously irrigated with saline (Fig. 6). Subsequently, HoLEP was successfully executed using the en bloc enucleation technique for complete drainage of the prostatic abscess and removal of the hyperplastic tissue. Tissue morcellation was performed using the VersaCut Tissue Morcellator (Lumenis Ltd.), with a morcellation time of approximately 10 minutes. The total operative time was 60 minutes.Fig. 6Seminal vesiculoscopy revealed pus formation (black arrow) within the seminal vesicle Seminal vesiculoscopy revealed pus formation (black arrow) within the seminal vesicle Anti-infective therapy was continued postoperatively. The catheter was removed on postoperative day 4, and the patient was discharged after successful spontaneous voiding. At the 1-month follow-up, prostate MRI showed appropriate postoperative changes with resolving abnormal signals in the prostate and seminal vesicles, consistent with post-treatment resolution of the abscesses (Fig. 7). The patient's symptoms were significantly improved: Qmax was 22 mL/second, IPSS was 8, and QOL was 2. The morcellated prostatic tissue was sent for histopathological examination, which confirmed benign prostatic hyperplasia with acute and chronic inflammatory changes, consistent with the clinical diagnosis of prostatic abscess. No malignant cells were identified.Fig. 7Postoperative prostate magnetic resonance imaging (MRI) demonstrated postoperative changes of prostatic abscess and seminal vesicle abscess. A Sagittal view. B and D Axial view. C Coronal view Postoperative prostate magnetic resonance imaging (MRI) demonstrated postoperative changes of prostatic abscess and seminal vesicle abscess. A Sagittal view. B and D Axial view. C Coronal view Discussion PA is an uncommon condition with potential morbidity and mortality [2]. Diagnosis is often delayed because its initial presentation mimics acute bacterial prostatitis. Digital rectal examination is frequently unreliable, showing fluctuation in a minority of cases. Therefore, accurate diagnosis relies on laboratory markers and definitive imaging [6]. MRI provides superior sensitivity over transrectal ultrasound for identifying multi-loculated abscesses and ruling out associated malignancies [7]. The standard management of PA combines antibiotic therapy with surgical drainage. Traditional methods include imaging-guided aspiration and TURP-U [8]. Simple aspiration carries a 20 to 30% recurrence rate due to incomplete drainage, particularly in multi-loculated lesions. Furthermore, TURP-U poses bleeding risks and may inadequately address underlying BPH. The choice of HoLEP over conventional drainage methods (aspiration or TURP-U) in our cases was based on its ability to achieve complete abscess clearance, excellent hemostasis, and simultaneous relief of BOO in a single session—advantages particularly relevant to our patients, who had large prostates (Case 1: 75 mL; Case 2: 65 mL), severe LUTS, and multi-loculated or concurrent seminal vesicle abscesses. Traditional aspiration carries a 20–30% recurrence rate due to incomplete drainage, and TURP-U entails greater bleeding risk, especially in elderly or comorbid patients. HoLEP addresses both the infection and the underlying obstruction definitively, avoiding secondary procedures. For symptomatic BPH, a range of therapies are available, including pharmacotherapy, Minimally Invasive Surgical Techniques (MISTs), and laser techniques. Among these, HoLEP offers definitive enucleation and effective relief of BOO, which is especially advantageous when coexisting pathology such as abscess requires simultaneous surgical management [910]. HoLEP offers an alternative approach. It enables complete en bloc removal of the abscess wall and hyperplastic tissue under direct visualization. This simultaneously provides abscess drainage and relieves bladder-outlet obstruction (BOO). The laser’s hemostatic properties also minimize blood loss. Previous studies by Lee et al. [11] and Edgar et al. [12] demonstrated the safety and efficacy of holmium laser unroofing for multi-loculated PA, even in patients with coagulopathy. Case 1 highlights this advantage, as HoLEP effectively treated both severe BOO and a large PA in a single session. Based on our preliminary experience, this approach is particularly preferred for patients with multi-loculated abscesses, lesions larger than 3 cm, or significant underlying BOO. Secondary seminal vesicle abscess (SVA) following PA is a rare but severe complication lacking standardized management guidelines [13]. Primary SVA is typically managed with aspiration, which has a high recurrence rate (15 to 30%) and fails to resolve underlying ejaculatory duct obstruction (EDO) [14]. For complex cases like Case 2, we utilized a combined approach of HoLEP and seminal vesiculoscopy. This single-access strategy provides comprehensive drainage. HoLEP addresses the prostatic obstruction, while seminal vesiculoscopy allows direct-vision exploration and irrigation of the SVA cavity. Additionally, it identifies and treats underlying anatomical causes such as EDO or calculi. The 60-minute operative time in Case 2 suggests this combined endoscopic procedure is efficient. Despite the promising results, the application of HoLEP, especially in combination with seminal vesiculoscopy for PA/SVA, is subject to several important limitations. First, the short follow-up period of only 1 month is a significant limitation. While this timeframe is sufficient to assess early postoperative outcomes such as symptom improvement, flow rate recovery, and immediate abscess resolution, it is inadequate for evaluating long-term outcomes including late recurrence, residual cavity changes, and durable voiding function. Longer follow-up (6 and 12 months) is currently ongoing for both patients and will be reported in future studies. Second, the small sample size (only two cases) limits the generalizability of our findings. PA with secondary SVA is an extremely rare condition, and large case series are difficult to accumulate; nevertheless, multicenter collaborative studies are needed to validate the safety and efficacy of this combined approach. Third, the steep learning curve for HoLEP requires significant urological expertise. However, studies have shown that even beginners can achieve acceptable success rates after completing the initial learning phase [15]. Fourth, the procedure is not suitable for hemodynamically unstable septic patients, who require immediate percutaneous drainage. Fifth, both patients had negative cultures, which may have been influenced by prior antibiotic exposure; this limits our ability to provide specific pathogen-directed therapy recommendations. Finally, our findings are based on a case series without a control group, and the lack of evidence from randomized controlled trials means that the comparative effectiveness of this approach versus traditional methods remains to be established. Further multicenter, prospective studies with larger sample sizes and longer follow-up are needed to validate the safety and long-term functional efficacy of this combined endoscopic strategy. Conclusions Combined HoLEP and seminal vesiculoscopy appears to be a feasible and minimally invasive option for managing complex prostatovesicular abscesses. It allows for simultaneous abscess drainage and BOO relief, though long-term efficacy and recurrence rates remain to be established through extended observation.